Скачать или смотреть AI platform identifies patient-specific drug combinations for treatment of lymphoma

A new artificial intelligence platform is being touted as key for patients whose lymphomas have relapsed. It is called the quadratic phenotypic optimisation platform (QPOP). Small tumour samples are collected from patients and incubated in a lab with 12 selected drugs used for lymphoma. After 72 hours, the QPOP ranks the potential response of the cancer cells to more than 750 distinct drug combinations, using up to four of those 12 possible drugs. Dr Anand Jeyasekharan, Consultant at the Department Haemotology-Oncology at the National University Cancer Institute, Singapore, shared more details.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook:   / channelnewsasia  
Instagram:   / channelnewsasia  
Twitter:   / channelnewsasia  
TikTok:   / channelnewsasia